Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Genprex Receives Approval to Advance Clinical Trial of REQORSA® in Combination with Tagrisso® in Advanced Non-Small Cell Lung Cancer
Genprex, a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer […]
Biological Dynamics Case Report Published in "Frontiers in Oncology" Demonstrates Advancement in the Detection of Early-Stage Pancreatic Lesions
Biological Dynamics, a life sciences company focused on developing and commercializing exosome isolation technology for […]
AMP945 Combined with FOLFIRINOX Enhances Treatment Effects in model of Pancreatic Cancer
Amplia Therapeutics is pleased to announce new data showing the efficacy of its investigational FAK […]
Terran Biosciences Announces New Breakthroughs in the Chemistry of MDMA
Terran Biosciences, a biotech platform company dedicated to the development of transformational therapeutics for neurological […]
Marinus Pharmaceuticals Receives Positive CHMP Opinion for ZTALMY® (ganaxolone) for the Adjunctive Treatment of Seizures Associated With CDKL5 Deficiency Disorder
Marinus Pharmaceuticals, a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure […]
IMFINZI® (durvalumab) plus LYNPARZA® (olaparib) and IMFINZI alone both significantly improved progression-free survival in advanced endometrial cancer when added to chemotherapy
Positive high-level results from the DUO-E Phase III trial showed IMFINZI® (durvalumab) in combination with […]
Shattuck Labs to Present Complete Dose-Escalation Data from Phase 1A Monotherapy Clinical Trial of SL-172154 in Platinum-Resistant Ovarian Cancer
Shattuck Labs, a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a […]
Syros Presents Data from Phase 1/1b Clinical Trial of SY-5609 in Advanced Solid Tumors at ASCO Annual Meeting
Syros Pharmaceuticals, a biopharmaceutical company committed to advancing new standards of care for the frontline […]
Vigeo Therapeutics New Immune Profiling and Biomarker Data Ph I/II Expansion Study in GBM Patients
Vigeo Therapeutics, a clinical-stage immuno-oncology company pioneering novel cancer therapies, has announced encouraging new data […]
Genome Medical Supporting Beam Therapeutics on its Sickle Cell Disease Clinical Trial
Genome Medical, the leading telehealth provider of genetic services and solutions, is teaming up with […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more